FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $121,000 | -2.4% | 24,100 | 0.0% | 0.05% | -34.2% |
| Q1 2018 | $124,000 | -14.5% | 24,100 | 0.0% | 0.07% | +19.7% |
| Q4 2017 | $145,000 | +8.2% | 24,100 | 0.0% | 0.06% | +56.4% |
| Q3 2017 | $134,000 | +19.6% | 24,100 | 0.0% | 0.04% | -11.4% |
| Q2 2017 | $112,000 | -47.4% | 24,100 | -44.0% | 0.04% | -30.2% |
| Q1 2017 | $213,000 | -86.0% | 43,000 | -68.6% | 0.06% | -88.7% |
| Q4 2016 | $1,521,000 | +19.9% | 137,000 | 0.0% | 0.56% | +44.9% |
| Q3 2016 | $1,269,000 | +95.8% | 137,000 | +34.3% | 0.38% | +40.0% |
| Q2 2016 | $648,000 | -2.6% | 102,000 | 0.0% | 0.28% | -8.9% |
| Q1 2016 | $665,000 | -19.6% | 102,000 | 0.0% | 0.30% | -13.5% |
| Q4 2015 | $827,000 | +10.6% | 102,000 | 0.0% | 0.35% | -18.3% |
| Q3 2015 | $748,000 | – | 102,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
| DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
| Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
| DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
| Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
| Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
| Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
| Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |